Efficacy of Strattera in children and adolescents with attention deficit hyperactivity disorder

被引：0
|
作者：
Vakula I.N. [1 ,2 ]
Vasyanina Yu.Sh. [2 ]
Gorbunova Z.Kh. [2 ]
Nikiforova E.Yu. [2 ]
Ponomarenko E.I. [2 ]
机构：
[1] Department of Psychiatry, Faculty of Advanced Education and Specialist Training, Kuban State Medical University, Kuban
[2] Specialist Clinical Psychiatric Hospital No. 1, Krasnodar
来源：
Neuroscience and Behavioral Physiology | 2010年 / 40卷 / 9期
关键词：
Attention deficit hyperactivity disorder; Efficacy; Safety; Strattera;
D O I：
10.1007/s11055-010-9365-6
中图分类号：
学科分类号：
摘要：
Children and adolescents (25 boys, nine girls, aged from six to 17 years) with attention deficit hyperactivity disorder (ADHD) were treated with Strattera at the optimal dose of 1.2 mg/day in out-patient conditions. After use of Strattera for three months, assessment of treatment efficacy demonstrated marked and moderate clinical effects in 78.1% of patients. Psychologists' assessment indicated that 80% of children showed improvements in the volume and rate of switching of attention and almost 60% showed improvements in measures of the stability of attention. EEG studies showed decreases in the "index of slowing" in 70.2% of patients. Strattera was found to have good safety and tolerance in the treatment of children and adolescents with ADHD. © 2010 Springer Science+Business Media, Inc.
引用
收藏
页码：1034 / 1037
页数：3
相关论文
共 50 条
  • [1] Effectiveness of strattera in children and adolescents with attention deficit hyperactivity disorder
    Vakula, I. N.
    Vasyanina, Yu Sh.
    Gorbunova, Z. H.
    Nikiforova, E. Yu.
    Ponomarenko, E. I.
    [J]. ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2009, 109 (08) : 42 - 44
  • [2] Efficacy of Attention Deficit Hyperactivity Disorder treatments in children and adolescents
    Jarque Fernandez, Sonia
    [J]. ANUARIO DE PSICOLOGIA, 2012, 42 (01): : 19 - U134
  • [3] Efficacy of atomoxetine in children and adolescents with attention deficit/hyperactivity disorder
    Yamamuro, K.
    Ueda, J.
    Takada, R.
    Yoshikawa, H.
    Aoki, C.
    Inoue, Y.
    Azechi, T.
    Yamamoto, S.
    Furuyama, T.
    Kishimoto, T.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S713 - S714
  • [4] Efficacy of atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder
    Dunn, D
    Allen, A
    Thomason, C
    Zhang, S
    Michelson, D
    Kelsey, D
    [J]. ANNALS OF NEUROLOGY, 2003, 54 : S143 - S143
  • [5] Attention deficit hyperactivity disorder in children and adolescents
    Flisher, A. J.
    Hawkridge, S.
    [J]. SOUTH AFRICAN JOURNAL OF PSYCHIATRY, 2013, 19 (03) : 136 - 140
  • [6] Atomoxetine (Strattera®), an alternative in the treatment of attention-deficit/hyperactivity disorder (ADHD) in children
    Gaillez, C.
    Sorbara, F.
    Perrin, E.
    [J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2007, 33 (04): : 621 - 628
  • [7] Efficacy and safety of atomoxetine in the treatment of attention deficit/hyperactivity disorder in children and adolescents
    Brown, WJ
    Biederman, J
    Spencer, T
    Heiligenstein, J
    Wernicke, J
    Allen, AJ
    Faries, D
    Michelson, D
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S411 - S411
  • [8] Efficacy and Safety of Atomoxetine in the Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder
    Kohn, Michael R.
    Tsang, Tracey W.
    Clarke, Simon D.
    [J]. CLINICAL MEDICINE INSIGHTS-PEDIATRICS, 2012, 6 : 95 - 162
  • [9] Efficacy and Tolerability of Different Interventions in Children and Adolescents with Attention Deficit Hyperactivity Disorder
    Luan, Ruiling
    Mu, Zhiling
    Yue, Fang
    He, Shaoying
    [J]. FRONTIERS IN PSYCHIATRY, 2017, 8
  • [10] Attention Deficit-Hyperactivity Disorder in Children and Adolescents
    Feldman, Heidi M.
    Reiff, Michael I.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (09): : 838 - 846
12345